Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis
Publication date
2019-04-01
Authors
van Nuland, Merel
Groenland, Steffie
Bergman, Andre M
Rotmans, Joris I
Rosing, Hilde
Beijnen, Jos H
Huitema, Alwin D.R.
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Keywords
Enzalutamide, Hemodialysis, Metabolites, Prostate cancer, Renal failure, Urology, Oncology, Journal Article
Citation
van Nuland, M, Groenland, S, Bergman, A M, Rotmans, J I, Rosing, H, Beijnen, J H & Huitema, A D R 2019, 'Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis', Clinical genitourinary cancer, vol. 17, no. 2, pp. e383-e386. https://doi.org/10.1016/j.clgc.2018.12.004